Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1, indicating a minor version update with no user-facing changes observed. The change does not affect core content, navigation, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded PubMed auto-fill notice and updated the page revision to v3.3.1; refined the publication attribution language. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check32 days agoChange DetectedAdded Tainan, Taiwan, 704 as a study location and removed the Tainan City, Taiwan, 704 entry along with the government funding lapse notice.SummaryDifference0.1%

- Check46 days agoChange DetectedNo significant changes detected; the Study Details page content and structure appear unchanged.SummaryDifference0.1%

- Check68 days agoChange DetectedThe reference was updated from an ahead-of-print notice with a July 2025 date to the final September 2025 publication date, removing the online-ahead-of-print note.SummaryDifference0.2%

- Check76 days agoChange DetectedUpdated location name from Blankenfelde to Blankenfelde-Mahlow, Brandenburg, Germany, 15831, and upgraded software revision from v3.0.2 to v3.2.0.SummaryDifference0.2%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.